John R. Schreiber - Publications

Affiliations: 
Case Western Reserve University School of Medicine, Cleveland, OH, United States 
Area:
Microbiology Biology, Immunology

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Schreiber JR. Role of Toll like receptors in the antibody response to encapsulated bacteria. Frontiers in Bioscience (Elite Edition). 4: 2638-46. PMID 22652666 DOI: 10.2741/E571  0.432
2012 Taylor CE, Cobb BA, Rittenhouse-Olson K, Paulson JC, Schreiber JR. Carbohydrate moieties as vaccine candidates: targeting the sweet spot in the immune response. Vaccine. 30: 4409-13. PMID 22575168 DOI: 10.1016/J.Vaccine.2012.04.090  0.336
2012 Greenspan NS, Lu MA, Shipley JW, Ding X, Li Q, Sultana D, Kollaros M, Schreiber JR, Fu P, Putterman C, Emancipator SN. IgG3 deficiency extends lifespan and attenuates progression of glomerulonephritis in MRL/lpr mice. Biology Direct. 7: 3. PMID 22248284 DOI: 10.1186/1745-6150-7-3  0.335
2011 Lai Z, Schreiber JR. Outer membrane protein complex of Meningococcus enhances the antipolysaccharide antibody response to pneumococcal polysaccharide-CRM₁₉₇ conjugate vaccine. Clinical and Vaccine Immunology : Cvi. 18: 724-9. PMID 21450979 DOI: 10.1128/Cvi.00053-11  0.398
2010 Lucas AH, Rittenhouse-Olson K, Kronenberg M, Apicella MA, Wang D, Schreiber JR, Taylor CE. Carbohydrate Moieties as Vaccine Candidates: meeting summary. Vaccine. 28: 1121-31. PMID 18579261 DOI: 10.1016/J.Vaccine.2008.05.055  0.355
2009 Lai Z, Schreiber JR. Antigen processing of glycoconjugate vaccines; the polysaccharide portion of the pneumococcal CRM(197) conjugate vaccine co-localizes with MHC II on the antigen processing cell surface. Vaccine. 27: 3137-44. PMID 19446183 DOI: 10.1016/J.Vaccine.2009.03.064  0.348
2007 Kaur K, Chowdhury S, Greenspan NS, Schreiber JR. Decreased expression of tumor necrosis factor family receptors involved in humoral immune responses in preterm neonates. Blood. 110: 2948-54. PMID 17634409 DOI: 10.1182/Blood-2007-01-069245  0.345
2007 McLean MD, Almquist KC, Niu Y, Kimmel R, Lai Z, Schreiber JR, Hall JC. A human anti-Pseudomonas aeruginosa serotype O6ad immunoglobulin G1 expressed in transgenic tobacco is capable of recruiting immune system effector function in vitro. Antimicrobial Agents and Chemotherapy. 51: 3322-8. PMID 17606688 DOI: 10.1128/Aac.00366-07  0.347
2006 John CC, Schreiber JR. Therapies and vaccines for emerging bacterial infections: learning from methicillin-resistant Staphylococcus aureus. Pediatric Clinics of North America. 53: 699-713. PMID 16873000 DOI: 10.1016/J.Pcl.2006.05.004  0.302
2005 Lai Z, Kimmel R, Petersen S, Thomas S, Pier G, Bezabeh B, Luo R, Schreiber JR. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes. Vaccine. 23: 3264-71. PMID 15837231 DOI: 10.1016/J.Vaccine.2005.01.088  0.38
2004 Maaser C, Housley MP, Iimura M, Smith JR, Vallance BA, Finlay BB, Schreiber JR, Varki NM, Kagnoff MF, Eckmann L. Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infection and Immunity. 72: 3315-24. PMID 15155635 DOI: 10.1128/Iai.72.6.3315-3324.2004  0.377
2004 Latz E, Franko J, Golenbock DT, Schreiber JR. Haemophilus influenzae type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity. Journal of Immunology (Baltimore, Md. : 1950). 172: 2431-8. PMID 14764714 DOI: 10.4049/Jimmunol.172.4.2431  0.371
2003 Canaday DH, Gehring A, Leonard EG, Eilertson B, Schreiber JR, Harding CV, Boom WH. T-cell hybridomas from HLA-transgenic mice as tools for analysis of human antigen processing. Journal of Immunological Methods. 281: 129-42. PMID 14580887 DOI: 10.1016/J.Jim.2003.07.004  0.313
2003 McCool TL, Schreiber JR, Greenspan NS. Genetic variation influences the B-cell response to immunization with a pneumococcal polysaccharide conjugate vaccine. Infection and Immunity. 71: 5402-6. PMID 12933893 DOI: 10.1128/Iai.71.9.5402-5406.2003  0.341
2003 Leonard EG, Canaday DH, Harding CV, Schreiber JR. Antigen processing of the heptavalent pneumococcal conjugate vaccine carrier protein CRM(197) differs depending on the serotype of the attached polysaccharide. Infection and Immunity. 71: 4186-9. PMID 12819115 DOI: 10.1128/Iai.71.7.4186-4189.2003  0.36
2003 Kamboj KK, Kirchner HL, Kimmel R, Greenspan NS, Schreiber JR. Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier protein. The Journal of Infectious Diseases. 187: 1629-38. PMID 12721943 DOI: 10.1086/374785  0.399
2002 Gor DO, Ding X, Li Q, Schreiber JR, Dubinsky M, Greenspan NS. Enhanced immunogenicity of pneumococcal surface adhesin A by genetic fusion to cytokines and evaluation of protective immunity in mice. Infection and Immunity. 70: 5589-95. PMID 12228286 DOI: 10.1128/Iai.70.10.5589-5595.2002  0.367
2002 McLay J, Leonard E, Petersen S, Shapiro D, Greenspan NS, Schreiber JR. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1. Journal of Immunology (Baltimore, Md. : 1950). 168: 3437-43. PMID 11907102 DOI: 10.4049/Jimmunol.168.7.3437  0.372
2001 Kamboj KK, King CL, Greenspan NS, Kirchner HL, Schreiber JR. Immunization with Haemophilus influenzae type b-CRM(197) conjugate vaccine elicits a mixed Th1 and Th2 CD(4+) T cell cytokine response that correlates with the isotype of antipolysaccharide antibody. The Journal of Infectious Diseases. 184: 931-5. PMID 11528593 DOI: 10.1086/323342  0.382
2001 Hemachandra S, Kamboj K, Copfer J, Pier G, Green LL, Schreiber JR. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis. Infection and Immunity. 69: 2223-9. PMID 11254577 DOI: 10.1128/Iai.69.4.2223-2229.2001  0.404
2000 Chu RS, McCool T, Greenspan NS, Schreiber JR, Harding CV. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies. Infection and Immunity. 68: 1450-6. PMID 10678959 DOI: 10.1128/Iai.68.3.1450-1456.2000  0.412
1999 McCool TL, Harding CV, Greenspan NS, Schreiber JR. B- and T-cell immune responses to pneumococcal conjugate vaccines: divergence between carrier- and polysaccharide-specific immunogenicity. Infection and Immunity. 67: 4862-9. PMID 10456942 DOI: 10.1128/Iai.67.9.4862-4869.1999  0.377
1998 Shapiro DA, Threadgill DS, Copfer MJ, Corey DA, McCool TL, McCormick LL, Magnuson TR, Greenspan NS, Schreiber JR. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides undergo normal isotype switching after immunization with polysaccharide-protein conjugate vaccines. Journal of Immunology (Baltimore, Md. : 1950). 161: 3393-9. PMID 9759856  0.301
1998 Threadgill DS, McCormick LL, McCool TL, Greenspan NS, Schreiber JR. Mitogenic synthetic polynucleotides suppress the antibody response to a bacterial polysaccharide. Vaccine. 16: 76-82. PMID 9607013 DOI: 10.1016/S0264-410X(97)00151-5  0.416
1996 Threadgill D, Mccool T, Greenspan N, Schreiber JR. A mitogenic synthetic polynucleolide suppresses LPS-O polysacchandc specific antibody response Faseb Journal. 10.  0.303
1995 Tosi MF, Zakem-Cloud H, Demko CA, Schreiber JR, Stern RC, Konstan MW, Berger M. Cross-sectional and longitudinal studies of naturally occurring antibodies to pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection Journal of Infectious Diseases. 172: 453-461. PMID 7622889 DOI: 10.1093/Infdis/172.2.453  0.343
1994 Schreiber JR, Dahlhauser P. Immunogenicity of tetanus toxoid conjugates of anti-idiotypes that mimic Pseudomonas aeruginosa surface polysaccharides Infection and Immunity. 62: 308-312. PMID 8262644 DOI: 10.1128/Iai.62.1.308-312.1994  0.409
1994 Berger M, Norvell TM, Tosi MF, Emancipator SN, Konstan MW, Schreiber JR. Tissue-specific fc γ and complement receptor expression by alveolar macrophages determines relative importance of igg and complement in promoting phagocytosis of pseudomonas aeruginosa Pediatric Research. 35: 68-77. PMID 8134202 DOI: 10.1203/00006450-199401000-00015  0.309
1993 Schreiber JR, Cooper LJN, Diehn S, Dahlhauser PA, Tosi MF, Glass DD, Patawaran M, Greenspan NS. Variable region-identical monoclonal antibodies of different igg subclass directed to pseudomonas aeruginosa lipopolysaccharide o-specific side chain function differently Journal of Infectious Diseases. 167: 221-226. PMID 8418172 DOI: 10.1093/Infdis/167.1.221  0.396
1993 Schreiber JR. Anti-idiotype vaccines for immunity to bacterial polysaccharides: induction of functional antibodies to polysaccharide antigens of Pseudomonas aeruginosa Springer Seminars in Immunopathology. 15: 235-246. PMID 7504840 DOI: 10.1007/Bf00201104  0.42
1991 Schreiber JR, Pier GB, Grout M, Nixon K, Patawaran M. Induction of opsonic antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide by an anti-idiotypic monoclonal antibody. The Journal of Infectious Diseases. 164: 507-14. PMID 1831226 DOI: 10.1093/Infdis/164.3.507  0.401
1988 Sood SK, Schreiber JR, Siber GR, Daum RS. Postvaccination susceptibility to invasive Haemophilus influenzae type b disease in infant rats. The Journal of Pediatrics. 113: 814-9. PMID 3263486 DOI: 10.1016/S0022-3476(88)80006-4  0.361
1987 Schreiber JR, Basker CJ, Siber GR. Effect of complement depletion on anticapsular-antibody-mediated immunity to experimental infection with Haemophilus influenzae type b Infection and Immunity. 55: 2830-2833. PMID 3499398 DOI: 10.1128/Iai.55.11.2830-2833.1987  0.391
1987 Sood SK, Schreiber JR, Siber GR, Daum RS. SUSCEPTIBILITY TO INVASIVE H. INFLUENZAE (Hi) INFECTION IMMEDIATELY AFTER IMMUNIZATION WITH THE CAPSULAR VACCINE Pediatric Research. 21: 335A-335A. DOI: 10.1203/00006450-198704010-01005  0.373
1987 Schreiber J, Basker C, Priehs C, Siber G. Deleterious Effect Of Immune Globulin In The Treatment Of H. Influenzae B Infection In Infant Rats Pediatric Research. 21: 334-334. DOI: 10.1203/00006450-198704010-00999  0.307
1986 Schreiber JR, Barrus V, Lynn Cates K, Siber GR. Functional characterization of human igg, igm, and iga antibody directed to the capsule of haemophilus influenzae type b Journal of Infectious Diseases. 153: 8-16. PMID 3484506 DOI: 10.1093/Infdis/153.1.8  0.432
1985 Schreiber JR, Barrus VA, Siber GR. Decreased protective efficacy of reduced and alkylated human immune serum globulin in experimental infection with Haemophilus influenzae type b Infection and Immunity. 47: 142-148. PMID 3871195 DOI: 10.1128/Iai.47.1.142-148.1985  0.395
1985 Warren S, Schreiber JR, Epstein MF. In Reply American Journal of Diseases of Children. 139: 115. DOI: 10.1001/Archpedi.1985.02140040012011  0.308
1984 Schreiber J, Barrus V, Siber G. Comparison Of Native And Reduced And Alkylated Human Iv Immune Serum Globulin (Isg) In Experimental H. In Fluenzae Type B Infection Pediatric Research. 18. DOI: 10.1203/00006450-198404001-01153  0.322
1983 Ambrosino D, Schreiber JR, Daum RS, Siber GR. Efficacy of human hyperimmune globulin in prevention of Haemophilus influenzae type b disease in infant rats. Infection and Immunity. 39: 709-14. PMID 6601060 DOI: 10.1128/Iai.39.2.709-714.1983  0.404
Show low-probability matches.